Processa Pharmaceuticals (PCSA) Stock Chart & Stock Price History $0.23 -0.01 (-4.98%) Closing price 05/16/2025 04:00 PM EasternExtended Trading$0.23 0.00 (-1.58%) As of 05/16/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock Processa Pharmaceuticals Stock Price Performance The Processa Pharmaceuticals (PCSA) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 88.03%, with a year-to-date return of -73.44%. In the past month, the stock has increased 6.68%, reflecting recent market activity. As of the latest close, Processa Pharmaceuticals traded at $0.23 with a market cap of $1.24 million and volume of 808,635 shares. Five years ago, the stock traded at a split-adjusted price of $120.00, representing a 99.80% decrease over that period. At the time, it had a market cap of $32.92 million and a volume of 0 shares. Receive PCSA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Processa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-1.72%1 Month Performance+6.68%3 Month Performance-60.95%Year-To-Date Performance-73.44%1 Year Performance-88.03%5 Year Performance-99.80% PCSA Stock Chart for Saturday, May, 17, 2025 PCSA Chart by TradingView Processa Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/16/2025$0.25$0.23-4.98%$0.24$0.23808,635 shs$1.24 million05/15/2025$0.23$0.25+5.56%$0.25$0.223.24 million shs$1.30 million05/14/2025$0.23$0.23+2.09%$0.25$0.221.75 million shs$1.23 million05/13/2025$0.24$0.23-4.02%$0.24$0.23729,122 shs$1.21 million05/12/2025$0.24$0.24+0.67%$0.25$0.231.01 million shs$1.26 million05/09/2025$0.27$0.24-12.47%$0.27$0.241.91 million shs$1.25 million05/08/2025$0.26$0.27+5.20%$0.29$0.241.95 million shs$1.43 million05/07/2025$0.26$0.26-1.15%$0.27$0.241.50 million shs$1.36 million05/06/2025$0.25$0.26+5.85%$0.29$0.243.98 million shs$1.37 million05/05/2025$0.23$0.25+6.30%$0.27$0.222.32 million shs$1.30 million Get the Latest News and Ratings for PCSA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Processa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/02/2025$0.25$0.23-7.40%$0.24$0.23736,508 shs$1.22 million05/01/2025$0.26$0.25-2.99%$0.26$0.233.56 million shs$1.32 million04/30/2025$0.23$0.26+12.38%$0.26$0.2110.09 million shs$1.36 million04/29/2025$0.24$0.23-2.51%$0.24$0.22586,394 shs$1.21 million04/28/2025$0.24$0.24-0.80%$0.25$0.23246,808 shs$1.24 million04/25/2025$0.24$0.24-0.71%$0.25$0.22375,101 shs$1.25 million04/24/2025$0.24$0.24-0.13%$0.25$0.22454,967 shs$1.26 million04/23/2025$0.22$0.24+8.43%$0.25$0.20817,065 shs$1.26 million04/22/2025$0.22$0.22+0.27%$0.24$0.211.10 million shs$1.16 million04/21/2025$0.22$0.22$0.24$0.191.17 million shs$1.16 million04/18/2025$0.22$0.22$0.26$0.151.28 million shs$1.16 million04/17/2025$0.25$0.22-13.39%$0.26$0.151.28 million shs$1.16 million04/16/2025$0.27$0.25-5.96%$0.27$0.231.55 million shs$1.34 million04/15/2025$0.26$0.27+4.57%$0.32$0.255.26 million shs$1.42 million Related Companies Dermata Therapeutics Stock Price Chart Soligenix Stock Price Chart Polyrizon Stock Price Chart Klotho Neurosciences Stock Price Chart Palatin Technologies Stock Price Chart Evoke Pharma Stock Price Chart Aptorum Group Stock Price Chart Alaunos Therapeutics Stock Price Chart Adial Pharmaceuticals Stock Price Chart Onconetix Stock Price Chart Receive PCSA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Processa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PCSA) was last updated on 5/17/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredWashington Is Broke—and Eyeing Your Savings NextWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Processa Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Processa Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.